BFA
BlackRock Fund Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $898M | Buy |
2,447,609
+157,214
| +7% | +$57.7M | 0.17% | 90 |
|
|
2016
Q3 | $921M | Buy |
2,290,395
+68,436
| +3% | +$27.5M | 0.19% | 84 |
|
|
2016
Q2 | $776M | Buy |
2,221,959
+13,282
| +0.6% | +$4.64M | 0.17% | 96 |
|
|
2016
Q1 | $796M | Buy |
2,208,677
+113,864
| +5% | +$41M | 0.18% | 85 |
|
|
2015
Q4 | $1.14B | Sell |
2,094,813
-192,163
| -8% | -$104M | 0.26% | 58 |
|
|
2015
Q3 | $1.06B | Buy |
2,286,976
+167,718
| +8% | +$78M | 0.28% | 53 |
|
|
2015
Q2 | $1.08B | Buy |
2,119,258
+58,979
| +3% | +$30.1M | 0.26% | 55 |
|
|
2015
Q1 | $930M | Buy |
2,060,279
+114,662
| +6% | +$51.8M | 0.22% | 61 |
|
|
2014
Q4 | $798M | Buy |
1,945,617
+40,580
| +2% | +$16.6M | 0.2% | 70 |
|
|
2014
Q3 | $687M | Buy |
1,905,037
+448,225
| +31% | +$162M | 0.19% | 69 |
|
|
2014
Q2 | $412M | Sell |
1,456,812
-41,473
| -3% | -$11.7M | 0.12% | 153 |
|
|
2014
Q1 | $450M | Sell |
1,498,285
-348,819
| -19% | -$105M | 0.13% | 119 |
|
|
2013
Q4 | $508M | Buy |
1,847,104
+112,631
| +6% | +$31M | 0.15% | 95 |
|
|
2013
Q3 | $543M | Buy |
1,734,473
+215,249
| +14% | +$67.3M | 0.18% | 78 |
|
|
2013
Q2 | $342M | Buy |
+1,519,224
| New | +$342M | 0.13% | 131 |
|